Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter examine.
Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in youngsters with chronic hepatitis B: the younger the higher. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: components related to response. Lamivudine and excessive-dose interferon alpha 2a combination remedy in naïve HBeAg-optimistic immunoactive chronic hepatitis B in children: an East Mediterranean heart's experience.
Interferon alfa therapy for chronic hepatitis B in youngsters: a multinational randomized managed trial. Interferon alfa-2b together with ribavirin for the remedy of chronic hepatitis C in youngsters: efficacy, security, and pharmacokinetics. Liver histology of kids with chronic hepatitis treated with interferon-a alone or in combination with lamivudine.

Comparison of antiviral impact of lamivudine with interferon-alpha2a versus -alpha2b in kids with chronic hepatitis B infection. Comparison of two totally different regimens of combined interferon-alpha2a and lamivudine therapy in children with chronic hepatitis B infection. Long-time period lamivudine therapy for chronic hepatitis B infection in children unresponsive to interferon.